227 related articles for article (PubMed ID: 29417253)
1. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
Calandri M; Yamashita S; Gazzera C; Fonio P; Veltri A; Bustreo S; Sheth RA; Yevich SM; Vauthey JN; Odisio BC
Eur Radiol; 2018 Jul; 28(7):2727-2734. PubMed ID: 29417253
[TBL] [Abstract][Full Text] [Related]
2. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
De Cobelli F; Calandri M; Della Corte A; Sirovich R; Gazzera C; Della Vigna P; Bonomo G; Varano GM; Maiettini D; Mauri G; Camisassi N; Steidler S; Ratti F; Gusmini S; Ronzoni M; Aldrighetti L; Odisio BC; Racca P; Fonio P; Veltri A; Orsi F
Eur Radiol; 2022 Jun; 32(6):4147-4159. PubMed ID: 35092474
[TBL] [Abstract][Full Text] [Related]
3. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.
Odisio BC; Yamashita S; Huang SY; Harmoush S; Kopetz SE; Ahrar K; Shin Chun Y; Conrad C; Aloia TA; Gupta S; Hicks ME; Vauthey JN
Br J Surg; 2017 May; 104(6):760-768. PubMed ID: 28240361
[TBL] [Abstract][Full Text] [Related]
4. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.
Odisio BC; Yamashita S; Huang SY; Kopetz SE; Ahrar K; Mizuno T; Conrad C; Aloia TA; Chun YS; Gupta S; Vauthey JN
J Vasc Interv Radiol; 2018 Mar; 29(3):395-403.e1. PubMed ID: 29395898
[TBL] [Abstract][Full Text] [Related]
5. Tailoring ablation strategies for colorectal liver metastases based upon rat sarcoma viral oncogene mutation status.
Calandri M; Odisio BC
Chin Clin Oncol; 2019 Oct; 8(5):51. PubMed ID: 31500432
[TBL] [Abstract][Full Text] [Related]
6. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
Brudvik KW; Mise Y; Chung MH; Chun YS; Kopetz SE; Passot G; Conrad C; Maru DM; Aloia TA; Vauthey JN
Ann Surg Oncol; 2016 Aug; 23(8):2635-43. PubMed ID: 27016292
[TBL] [Abstract][Full Text] [Related]
7. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.
Shady W; Petre EN; Do KG; Gonen M; Yarmohammadi H; Brown KT; Kemeny NE; D'Angelica M; Kingham PT; Solomon SB; Sofocleous CT
J Vasc Interv Radiol; 2018 Feb; 29(2):268-275.e1. PubMed ID: 29203394
[TBL] [Abstract][Full Text] [Related]
9. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
[TBL] [Abstract][Full Text] [Related]
10. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study.
Kurilova I; Bendet A; Petre EN; Boas FE; Kaye E; Gonen M; Covey A; Brody LA; Brown KT; Kemeny NE; Yarmohammadi H; Ziv E; D'Angelica MI; Kingham TP; Cercek A; Solomon SB; Beets-Tan RGH; Sofocleous CT
Clin Colorectal Cancer; 2021 Jun; 20(2):e82-e95. PubMed ID: 33246789
[TBL] [Abstract][Full Text] [Related]
12. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
Yamashita S; Odisio BC; Huang SY; Kopetz SE; Ahrar K; Chun YS; Conrad C; Aloia TA; Gupta S; Harmoush S; Hicks ME; Vauthey JN
Eur J Surg Oncol; 2017 Jun; 43(6):1040-1049. PubMed ID: 28187878
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
[TBL] [Abstract][Full Text] [Related]
14. RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.
Denbo JW; Yamashita S; Passot G; Egger M; Chun YS; Kopetz SE; Maru D; Brudvik KW; Wei SH; Conrad C; Vauthey JN; Aloia TA
J Gastrointest Surg; 2017 Jan; 21(1):68-77. PubMed ID: 27334313
[TBL] [Abstract][Full Text] [Related]
15. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.
Wang X; Sofocleous CT; Erinjeri JP; Petre EN; Gonen M; Do KG; Brown KT; Covey AM; Brody LA; Alago W; Thornton RH; Kemeny NE; Solomon SB
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):166-75. PubMed ID: 22535243
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter CT Hepatic Arteriography Compared with Conventional CT Fluoroscopy Guidance in Percutaneous Thermal Ablation to Treat Colorectal Liver Metastases: A Single-Center Comparative Analysis of 2 Historical Cohorts.
Puijk RS; Nieuwenhuizen S; van den Bemd BAT; Ruarus AH; Geboers B; Vroomen LGPH; Muglia R; de Jong MC; de Vries JJJ; Scheffer HJ; van den Tol PMP; Meijerink MR
J Vasc Interv Radiol; 2020 Nov; 31(11):1772-1783. PubMed ID: 32981819
[TBL] [Abstract][Full Text] [Related]
18. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
Brudvik KW; Jones RP; Giuliante F; Shindoh J; Passot G; Chung MH; Song J; Li L; Dagenborg VJ; Fretland ÅA; Røsok B; De Rose AM; Ardito F; Edwin B; Panettieri E; Larocca LM; Yamashita S; Conrad C; Aloia TA; Poston GJ; Bjørnbeth BA; Vauthey JN
Ann Surg; 2019 Jan; 269(1):120-126. PubMed ID: 28549012
[TBL] [Abstract][Full Text] [Related]
19. Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation.
Della Corte A; Mori M; Calabrese F; Palumbo D; Ratti F; Palazzo G; Pellegrini A; Santangelo D; Ronzoni M; Spezi E; Del Vecchio A; Fiorino C; Aldrighetti L; De Cobelli F
Int J Hyperthermia; 2024; 41(1):2349059. PubMed ID: 38754994
[TBL] [Abstract][Full Text] [Related]
20. The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.
Amikura K; Akagi K; Ogura T; Takahashi A; Sakamoto H
J Surg Oncol; 2018 Mar; 117(4):745-755. PubMed ID: 29194647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
